SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-033947
Filing Date
2023-07-24
Accepted
2023-07-24 08:41:12
Documents
13
Period of Report
2023-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20230720.htm   iXBRL 8-K 56371
2 EX-99.1 tlis-ex99_1.htm EX-99.1 11591
  Complete submission text file 0000950170-23-033947.txt   191868

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlis-20230720.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlis-20230720_pre.xml EX-101.PRE 10222
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlis-20230720_lab.xml EX-101.LAB 13904
7 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20230720_htm.xml XML 4889
Mailing Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065
Business Address 1100 ISLAND DRIVE SUITE 101 REDWOOD CITY CA 94065 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 231103832
SIC: 3826 Laboratory Analytical Instruments